tenofovir disoproxil fumarate ester
GPTKB entity
Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiviral drug |
| gptkbp:activeIngredient |
tenofovir disoproxil
|
| gptkbp:approvalYear |
2001
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AF07
|
| gptkbp:brand |
gptkb:Viread
|
| gptkbp:CASNumber |
202138-50-9
|
| gptkbp:chemicalFormula |
C19H30N5O10P·C4H4O4
|
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| gptkbp:eliminationHalfLife |
17 hours
|
| gptkbp:excretion |
renal
|
| https://www.w3.org/2000/01/rdf-schema#label |
tenofovir disoproxil fumarate ester
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
renal impairment
decreased bone mineral density |
| gptkbp:synonym |
gptkb:TDF
gptkb:tenofovir_DF |
| gptkbp:usedFor |
HIV infection
chronic hepatitis B |
| gptkbp:bfsParent |
gptkb:tenofovir_disoproxil_fumarate
|
| gptkbp:bfsLayer |
6
|